Isolation and Characterization of Patient-derived...
Abstract Pancreatic ductal adenocarcinoma (PDAC) is amongst the most lethal malignancies. Recently,...
publicationsLearn More>
Abstract Pancreatic ductal adenocarcinoma (PDAC) is amongst the most lethal malignancies. Recently,...
publicationsLearn More>
Abstract OBJECTIVE: Pancreatic ductal adenocarcinoma (PDAC) still carries a dismal prognosis with...
publicationsLearn More>
NEW YORK – Gene expression signatures uncovered using tumor-derived organoids could help...
newsLearn More>
Scientists at Cold Spring Harbor Laboratory (CSHL) say they have found a...
newsLearn More>
Abstract Despite untiring efforts to develop therapies for pancreatic ductal adenocarcinoma (PDAC),...
publicationsLearn More>
Cancer is relentless and resilient. When a drug blocks a cancer cell’s...
newsLearn More>
Abstract PURPOSE: KRAS is mutated in the majority of pancreatic ductal adenocarcinoma....
publicationsLearn More>
Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company, announced a new...
newsLearn More>
Pancreatic ductal adenocarcinoma (PDA) has a highly immunosuppressive microenvironment, which is contributed...
publicationsLearn More>
Sign up to receive
weekly updates!